Latest Close
$2.97
News
ADXN
Addex Therapeutics Ltd News
This news view pulls recent coverage and headlines tied to ADXN.
1y Change
-$6.63 (-69.06%)
Market Cap
$5,204,732.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
GlobeNewswire • Oct 8, 2026
Read articleAddex Therapeutics Announces Executive Management Changes
GlobeNewswire • Oct 2, 2026
Read articleAddex Therapeutics Ltd (ADXN) (Q2 2026) Earnings Call Highlights: Regained GABAB PAM Rights and ...
GuruFocus.com • Oct 1, 2026
Read articleAddex (ADXN) Q2 2026 Earnings Call Transcript
Motley Fool • Sep 29, 2026
Read articleAddex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
GlobeNewswire • Sep 28, 2026
Read articleAddex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior
GlobeNewswire • Sep 25, 2026
Read article